| Literature DB >> 27612641 |
Julien Ettersperger1, Nicolas Montcuquet1, Georgia Malamut2, Nicolas Guegan1, Silvia Lopez-Lastra3, Ségolène Gayraud1, Christian Reimann4, Elodie Vidal5, Nicolas Cagnard6, Patrick Villarese5, Isabelle Andre-Schmutz4, Rita Gomes Domingues7, Cristina Godinho-Silva7, Henrique Veiga-Fernandes7, Ludovic Lhermitte5, Vahid Asnafi5, Elizabeth Macintyre5, Christophe Cellier2, Kheira Beldjord8, James P Di Santo3, Nadine Cerf-Bensussan9, Bertrand Meresse10.
Abstract
The nature of gut intraepithelial lymphocytes (IELs) lacking antigen receptors remains controversial. Herein we showed that, in humans and in mice, innate intestinal IELs expressing intracellular CD3 (iCD3(+)) differentiate along an Id2 transcription factor (TF)-independent pathway in response to TF NOTCH1, interleukin-15 (IL-15), and Granzyme B signals. In NOTCH1-activated human hematopoietic precursors, IL-15 induced Granzyme B, which cleaved NOTCH1 into a peptide lacking transcriptional activity. As a result, NOTCH1 target genes indispensable for T cell differentiation were silenced and precursors were reprogrammed into innate cells with T cell marks including intracellular CD3 and T cell rearrangements. In the intraepithelial lymphoma complicating celiac disease, iCD3(+) innate IELs acquired gain-of-function mutations in Janus kinase 1 or Signal transducer and activator of transcription 3, which enhanced their response to IL-15. Overall we characterized gut T cell-like innate IELs, deciphered their pathway of differentiation and showed their malignant transformation in celiac disease.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27612641 DOI: 10.1016/j.immuni.2016.07.018
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745